Unlocking Patient Engagement: The FDA Wants You to Know This Career highs and lows sometimes feel random: We often call a success “lucky” and a setback “unfortunate.” In biopharma, we may think of a drug launch that turns out to be a blockbuster as such a lucky break. But possible setbacks lurk all along the drug life cycle: The molecule might not mee Written by Oliver Portmann March 11, 2024March 13, 2024
Patient Engagement: Navigating Commercial and Compliance Objectives By Jenn Mason, as published in PM360, June 16, 2023 Patient engagement is a classic “iceberg” field: There’s way more hidden below the surfact than the immediate optics suggest. For example, while people may intuit that empathy, logistical competence, and a call center infrast Written by Snow Staff June 20, 2023November 13, 2023
Every Pharma Marketer Should Apply These Regulatory Safeguards By Nicole Hoadley In March, I had the opportunity to participate in a panel at DIA. The topic was on influencer marketing and its legal and regulatory implications. The somewhat inconsistent way professionals use the vernacular is what stood out to me the most. We should fix that by clarifying Written by Snow Staff April 19, 2021April 20, 2022
The End of DTC? Time to Rethink Patient Engagement Written by Snow Staff November 11, 2025November 11, 2025
From Outreach to Ownership: Why Co-Creation Can’t Wait Written by Snow Staff September 25, 2025October 23, 2025
Beyond Awareness: Modeling Shared Decision-Making in Patient Communications Written by Snow Staff May 15, 2025October 23, 2025
Publication Day! Brenda Snow’s “Diagnosed” Available Now Written by Oliver Portmann March 18, 2025March 18, 2025
The Hidden Value of Patient Voices: Redefining Success in Healthcare Written by Amelia Eanes March 11, 2025October 23, 2025
